Enlarge your knowledge, read our wellbutrin sr 150mg connected fresh articles. Get ready for this peculiar cheap wellbutrin note.
Such risks and uncertainties include, but are not limited to, Impax's ability to obtain sufficient capital to fund its operations, the difficulty of predicting FDA filings and approvals, consumer acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, Impax's ability to successfully wellbutrin sr 150mg develop and commercialize pharmaceutical products, Impax's reliance on key strategic alliances, the uncertainty of patent litigation, the availability of raw materials, the regulatory environment, dependence on patent and other protection for innovative products, exposure to product liability claims, fluctuations in operating results and other risks detailed from time to time in Impax's filings with the Securities and Exchange Commission.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this news release contain information that is not historical, these statements are forward-looking in nature and express the beliefs and expectations of management. Such risks and uncertainties include, but are not limited to, Impax's ability to obtain sufficient capital to fund its operations, the difficulty of predicting FDA filings and approvals, consumer acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, Impax's ability to successfully develop and commercialize pharmaceutical products, Impax's reliance on key strategic alliances, the uncertainty of patent litigation, the availability of raw materials, the regulatory environment, dependence on patent and other protection for innovative products, exposure to product liability claims, fluctuations in operating results and other risks detailed from time to time in Impax's filings with the Securities and Exchange Commission. Securities and Exchange Commission. Wellbutrin sr 150mg the introduction of Bupropion HCI, ER 150mg tablets represents another first to market product for Eon Labs. Without limiting the generality of the foregoing, words such as may, will, to, plan, expect, wellbutrin sr 150mg believe, anticipate, intend, could, would, estimate, or continue or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Fifteen of these filings Wellbutrin sr 150mg were made under Paragraph IV of the Hatch-Waxman Amendments. Forward-looking statements speak only as to the date on which they are made, and Impax undertakes no obligation to update publicly or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise. HAYWARD -- Impax Laboratories launched its generic version of a major antidepression drug Monday, but the bad news for the company is that competitor wellbutrin sr 150mg eon Labs is now launching its version six months earlier than expected. Wellbutrin SR brought in $1. 2 billion in sales for GlaxoSmith Kline last year. Sales of over wellbutrin sr 150mg $1. 6 billion for the twelve-month period ended March 31, 2003 according to IMS. IMPAX currently has 18 applications pending at the FDA, including five tentatively approved, wellbutrin sr 150mg which address approximately $5. 5 billion in U.
Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. The agreement provides, among other things, that if Andrx is unable to launch its own products within a defined period of time, and IMPAX is able to market its products, Andrx will enable IMPAX to launch its own products through Teva, with the parties sharing certain payments with Andrx relating to the sale of the products for a 180-day period. Should Andrx launch its own products prior to IMPAX launching its products, Andrx will share with Teva and IMPAX certain payments for a 180-day period.